Tag: 2026
CDSCO Advises Pharma Companies to Track and Report Drug Side Effects
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has issued a firm directive to all medicine manufacturers to build and maintain proper...
Emcure and Roche Collaborate to Improve Access to Advanced Nephrology Care
Emcure Pharmaceuticals has entered into a distribution agreement with Roche India for select products in nephrology and transplantation, marking a strategic step in expanding...
India’s Lupin and Natco Pharma Secure U.S. FDA Approval for Eribulin Mesylate Injection
On 03rd June, 2026 Lupin Limited (Lupin) announced that, Lupin and its alliance partner Natco Pharma Limited (Natco) got the approval from the United States Food and Drug Administration (U.S. FDA)...
Lilly’s Obesity Portfolio Wins Full U.S. Insurance Coverage, Reshaping the GLP-1 Landscape
In a pivotal shift for the obesity treatment market, Eli Lilly and Company (NYSE: LLY) has secured formulary coverage across all three of America's...
Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines
The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the Drugs (Prices Control) Order, 2013, with...
Dr. Reddy’s Makes History with Health Canada Approval of World’s First Generic Semaglutide Injection in a G7 Market
Dr. Reddy’s Laboratories Ltd.a leading global pharmaceutical company, is pleased to announce it has received a Notice of Compliance (NOC) from Health Canada for...